Stephenson Megan L, Wing Deborah A
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange, CA, USA.
Drug Des Devel Ther. 2015 Apr 22;9:2321-7. doi: 10.2147/DDDT.S64227. eCollection 2015.
Induction of labor is one of the most commonly performed obstetric procedures and will likely become more common as the reproductive population in developed nations changes. As the proportion of women undergoing induction grows, there is a constant search for more efficacious ways to induce labor while maintaining fetal and maternal safety as well as patient satisfaction. With almost half of induced labors requiring cervical ripening, methods for achieving active labor and vaginal delivery are constantly being investigated. Prostaglandins have been shown to be effective induction agents, and specifically vaginal misoprostol, used off-label, have been widely utilized to initiate cervical ripening and active labor. The challenge is to administer this medication accurately while maintaining the ability to discontinue the medication when needed. The misoprostol vaginal insert initiates cervical ripening utilizing a delivery system that controls medication release and can be rapidly removed. This paper reviews the design, development, and clinical utility of the misoprostol vaginal insert for induction of labor as well as patient considerations related to the delivery system.
引产是最常见的产科操作之一,随着发达国家生殖人群的变化,其可能会变得更加普遍。随着引产女性比例的增加,人们一直在不断寻找更有效的引产方法,同时维持胎儿和产妇的安全以及患者满意度。由于几乎一半的引产需要促宫颈成熟,实现自然分娩和阴道分娩的方法也在不断研究中。前列腺素已被证明是有效的引产药物,特别是未按药品说明书使用的阴道用米索前列醇,已被广泛用于启动宫颈成熟和自然分娩。挑战在于准确给药,同时保持在需要时停药的能力。米索前列醇阴道栓剂利用一种控制药物释放且可快速取出的给药系统启动宫颈成熟。本文综述了用于引产的米索前列醇阴道栓剂的设计、开发和临床应用,以及与给药系统相关的患者注意事项。